BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32965639)

  • 1. Interferon therapy for pregnant patients with essential thrombocythemia in Japan.
    Edahiro Y; Yasuda H; Gotoh A; Morishita S; Suzuki T; Takeda J; Ando J; Tsutsui M; Itakura A; Komatsu N
    Int J Hematol; 2021 Jan; 113(1):106-111. PubMed ID: 32965639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.
    Sakai K; Ueda A; Hasegawa M; Ueda Y
    Int J Hematol; 2018 Aug; 108(2):203-207. PubMed ID: 29290077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies.
    Passamonti F; Rumi E; Randi ML; Morra E; Cazzola M
    J Thromb Haemost; 2010 Feb; 8(2):411-3. PubMed ID: 19912517
    [No Abstract]   [Full Text] [Related]  

  • 4. Contemporary management of essential thrombocythemia in children.
    Randi ML; Bertozzi I; Putti MC
    Expert Rev Hematol; 2019 May; 12(5):367-373. PubMed ID: 30925843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha for essential thrombocythemia during 34 high-risk pregnancies: outcome and safety.
    Schrickel L; Heidel FH; Sadjadian P; Becker T; Kolatzki V; Hochhaus A; Griesshammer M; Wille K;
    J Cancer Res Clin Oncol; 2021 May; 147(5):1481-1491. PubMed ID: 33140210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebound of platelet count in a patient with type 2 calreticulin-mutant essential thrombocythemia in the postpartum period: A case report.
    Al-Mashdali AF; Yassin MA
    Medicine (Baltimore); 2021 Nov; 100(44):e27725. PubMed ID: 34871269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2020 Dec; 95(12):1599-1613. PubMed ID: 32974939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of interferon-alpha in essential thrombocythemia during pregnancy.
    Yoshida Y; Katsurada T; Nakabou Y; Kawabata H
    Ann Hematol; 2017 May; 96(5):877-878. PubMed ID: 28194492
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry.
    Melillo L; Tieghi A; Candoni A; Radaelli F; Ciancia R; Specchia G; Martino B; Scalzulli PR; Latagliata R; Palmieri F; Usala E; Valente D; Valvano MR; Cedrone M; Comitini G; Martinelli V; Cascavilla N; Gugliotta L
    Am J Hematol; 2009 Oct; 84(10):636-40. PubMed ID: 19705431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series.
    Beauverd Y; Radia D; Cargo C; Knapper S; Drummond M; Pillai A; Harrison C; Robinson S
    Haematologica; 2016 May; 101(5):e182-4. PubMed ID: 26819057
    [No Abstract]   [Full Text] [Related]  

  • 11. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
    Tefferi A; Barbui T
    Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential thrombocythaemia.
    Double G; Harrison C
    Hematology; 2015 Mar; 20(2):119-20. PubMed ID: 25715049
    [No Abstract]   [Full Text] [Related]  

  • 13. Anagrelide and Mutational Status in Essential Thrombocythemia.
    Iurlo A; Cattaneo D; Orofino N; Bucelli C; Fabris S; Cortelezzi A
    BioDrugs; 2016 Jun; 30(3):219-23. PubMed ID: 27041108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alfa treatment of essential thrombocythemia during pregnancy.
    Iwashita T; Fujitani M; Yamamoto Y; Katsurada T; Yoshida Y
    Intern Med; 2006; 45(20):1161-4. PubMed ID: 17106162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies.
    Gangat N; Wolanskyj AP; Schwager S; Tefferi A
    Eur J Haematol; 2009 May; 82(5):350-3. PubMed ID: 19243425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful pregnancy and delivery during alpha-interferon therapy for essential thrombocythemia].
    Iki S; Usuki K; Kotaki M; Yamaguchi Y; Urabe A
    Rinsho Ketsueki; 1999 Nov; 40(11):1201-3. PubMed ID: 10624133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single institutional experience with 43 pregnancies in essential thrombocythemia.
    Wright CA; Tefferi A
    Eur J Haematol; 2001 Mar; 66(3):152-9. PubMed ID: 11350483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia.
    How J; Leiva O; Bogue T; Fell GG; Bustoros MW; Connell NT; Connors JM; Ghobrial IM; Kuter DJ; Mullally A; Neuberg D; Zwicker JI; Fogerty AE; Hobbs GS
    Leuk Res; 2020 Nov; 98():106459. PubMed ID: 33022566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple gestation in an essential thrombocythemia patient treated with interferon-alpha.
    Nevruz O; Goktolga U; Avcu F; Ozsari L; Ural AU
    Acta Obstet Gynecol Scand; 2007; 86(7):893-5. PubMed ID: 17611839
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombopoietin Measurement as a Key Component in the Evaluation of Pediatric Thrombocytosis.
    Nelson ND; Marcogliese A; Bergstrom K; Scheurer M; Mahoney D; Bertuch AA
    Pediatr Blood Cancer; 2016 Aug; 63(8):1484-7. PubMed ID: 27100794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.